Advice

Indication withdrawn

The marketing authorisation for collagense clostridum histolyticum (Xiapex) has been withdrawn – see link

Medicine details

Medicine name:
collagenase clostridum histolyticum (Xiapex)
SMC ID:
1059/15
Indication:

Treatment of adult men with Peyronie' s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy.

Pharmaceutical company
Swedish Orphan
BNF chapter
Musculoskeletal and joint diseases
Submission type
Non submission
Status
Withdrawn
Date advice published
11 May 2015
Additional notes

The marketing authorisation for collagense clostridum histolyticum (Xiapex) has been withdrawn – see link